Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2025-12-24 @ 11:29 PM
NCT ID:
NCT02810756
Eligibility Criteria:
Inclusion Criteria:
* Locally advanced or metastatic cancer;
* Able and willing to give written consent;
* WHO performance status of 0, 1 or 2;
* Able and willing to undergo blood sampling for PK analysis;
* Minimal acceptable safety laboratory values;
* Negative pregnancy test for female patients with childbearing potential;
* Able and willing to swallow oral medication.
Exclusion Criteria:
* Any treatment with investigational drugs within 30 days prior to receiving the investigational treatment;
* Any treatment with CYP3A4, BCRP or PGP interfering drugs;
* Patients who received treatment with Votrient(R) kess than 1 week ago;
* Woman who are pregnant or breast feeding;
* Patients suffering from any known condition that may influence the dissolution or absorption of Pazopanib.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02810756
Study Brief:
Protocol Section:
NCT02810756